OptiVivax

Did you know that there are 5 parasite species causing malaria in humans, with Plasmodium falciparum and Plasmodium vivax posing the greatest threat? This #WorldMalariaDay, delve into Dr. Angela Minassian's insights on the Optivivax Consortium's mission to combat P. Vivax Malaria with a vaccine. Watch the 3-minute video for details! ?? Kavli Institute for Nanoscience Discovery, University of Oxford The Kavli Foundation University of Oxford The Department of Biochemistry, University of Oxford

Senior Clinical Trials Programme Manager - Vacancy ref 175310. Vacancy info here: https://lnkd.in/edXpm6d2. Join our expanding, friendly team and be part of cutting edge vaccine research. Professor Simon Draper leads a vaccine development programme, with a strong focus on malaria, antibody immunology and clinical trials. The Draper Group clinical team, led by Dr Angela Minassian, is based at the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital, and is fully integrated with the laboratory research team based at the Department of Biochemistry. This role will mainly be based at the CCVTM, however there will be some liaison required at the Department of Biochemistry, South Parks Road, Oxford.?The group’s current website is here: https://lnkd.in/emV8wmph. #recruitment, #sciencejobs, #malariajobs, #drapergroup

???Announcement: New Adjuvant Training Course Available ? VFI is pleased to announce that a new round of our training course,?Adjuvants and Vaccine Formulation, will take place in November 2024 in Geneva, Switzerland. This program is designed to provide comprehensive knowledge about adjuvants, formulation and the development of adjuvanted vaccines with different lectures and case studies. ? Course Details: Dates:?11th-14th of November 2024 Location:??Geneva, Switzerland Application deadline:?23rd of August 2024?via Transvac ? For more information and to apply, please visit: ?https://lnkd.in/eGFFV7ac?.? ? Should you have any questions, feel free to reach out.?We look forward to your participation. ?

DO SOMETHING AMAZING AND HELP US INVESTIGATE MALARIA! We are looking for volunteers to help us understand how our immune systems respond to repeated infection with malaria. ?? By taking part in this challenge study, you could help the research aimed at preventing hundreds of thousands of child deaths. ??If you are aged?18 to 45 years old, in good health and live in the Thames Valley, then you may be eligible to take part in the BIO-004 study. The total study duration is?20 months. All participants will be reimbursed for their time, inconvenience and travel?up to ￡9,100. ?? https://lnkd.in/dDhbp_cs University of Oxford | Oxford University Department of Paediatrics

Delighted to share our preclinical data on an improved blood-stage #malaria #vaccine candidate targeting #RH5 now published at #CellRepMed at Cell Press. Congrats to Lloyd King at University of Oxford and big thanks to our generous collaborators and partners. https://lnkd.in/eDr4y_GF The data in preclinical models show that a stabilised version of #RH5, called RH5.2, bioconjugated onto a virus-like particle (VLP) improves the level of in vitro parasite growth inhibition compared to the current RH5.1 vaccine. These data supported the RH5.2-VLP/Matrix-M? vaccine candidate to Phase 1a/b clinical trials now in progress.? Big thanks to support from partners, collaborators and funders: Novavax, PATH, USAID, Leidos, #NIAID, Kavli Institute for Nanoscience Discovery, University of Oxford, The Department of Biochemistry, University of Oxford, Jenner Institute, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) - University of Ghana, London School of Hygiene and Tropical Medicine, U. of London, Weizmann Institute of Science, ExpreS2ion Biotechnologies, Medical Research Council, Wellcome Trust, NIHR Oxford Biomedical Research Centre and European Commission.

We are #recruiting for a Project Manager to?join our team. If you’re keen to join a dynamic translational research group in Oxford, focussed on #vaccines and #malaria, then do check out the link. Come and join us! ?? https://lnkd.in/eaU5fn5Y

#TuesdayReads Check out the Simon Draper Group's latest publication! They explore how antibodies target PfRH5 to inhibit #malaria parasite invasion, providing insights for next-gen #vaccine design. Read more ??

Very pleased to share that our latest papers on blood-stage malaria antibodies are now available online at Cell.

?? Malaria remains a global health challenge with 240 million cases and 627,000 deaths in 2020. But we're on a mission to change this. Discover our malaria challenge study: BIO-001. ?? https://lnkd.in/dSxfBMbJ

We are #recruiting for a Project Manager to?join our team. If you’re keen to join a dynamic translational research group in Oxford, focussed on #vaccines and #malaria, then do check out the link. Come and join us! ?? https://lnkd.in/eaU5fn5Y